BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35385829)

  • 1. Adjuvant Hormone Therapy-Related Hot Flashes Predict Treatment Discontinuation and Worse Breast Cancer Prognosis.
    Zeng E; He W; Smedby KE; Czene K
    J Natl Compr Canc Netw; 2022 Apr; 20(6):683-689.e2. PubMed ID: 35385829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
    Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
    JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morning chronotype is a protective factor against chemotherapy-induced hot flashes in premenopausal women with breast cancer.
    Son KL; Jung D; Lee KM; Hwang H; Lee J; Kim TY; Im SA; Lee KH; Spiegel D; Hahm BJ
    Support Care Cancer; 2020 Mar; 28(3):1351-1358. PubMed ID: 31264189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial.
    Dezentjé VO; Gelderblom H; Van Schaik RH; Vletter-Bogaartz JM; Van der Straaten T; Wessels JA; Kranenbarg EM; Berns EM; Seynaeve C; Putter H; Van de Velde CJ; Nortier JW; Guchelaar HJ
    Breast Cancer Res Treat; 2014 Jan; 143(1):171-9. PubMed ID: 24265036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial adversity: association with discontinuation of adjuvant hormone therapy and breast cancer prognosis.
    Zeng E; He W; Sjölander A; Bergqvist J; Fang F; Czene K
    J Natl Cancer Inst; 2024 Jun; 116(6):920-928. PubMed ID: 38471102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot flashes and related outcomes in breast cancer survivors and matched comparison women.
    Carpenter JS; Johnson D; Wagner L; Andrykowski M
    Oncol Nurs Forum; 2002 Apr; 29(3):E16-25. PubMed ID: 11979290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant Discontinuation of Cardiovascular Therapy and Adjuvant Hormone Therapy Among Patients With Breast Cancer.
    He W; Zeng E; Sjölander A; Hübbert L; Hedayati E; Czene K
    JAMA Netw Open; 2023 Jul; 6(7):e2323752. PubMed ID: 37459096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen-induced hot flashes.
    Loprinzi CL; Zahasky KM; Sloan JA; Novotny PJ; Quella SK
    Clin Breast Cancer; 2000 Apr; 1(1):52-6. PubMed ID: 11899390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analyses.
    Hutton B; Yazdi F; Bordeleau L; Morgan S; Cameron C; Kanji S; Fergusson D; Tricco A; Straus S; Skidmore B; Hersi M; Pratt M; Mazzarello S; Brouwers M; Moher D; Clemons M
    Syst Rev; 2015 Aug; 4():114. PubMed ID: 26307105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors.
    Su HI; Sammel MD; Springer E; Freeman EW; DeMichele A; Mao JJ
    Breast Cancer Res Treat; 2010 Nov; 124(1):205-11. PubMed ID: 20182796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening.
    He W; Eriksson L; Törnberg S; Strand F; Hall P; Czene K
    BMC Med; 2019 Jan; 17(1):24. PubMed ID: 30700300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal symptoms among breast cancer patients: a potential indicator of favorable prognosis.
    Chen Y; Dorjgochoo T; Bao PP; Zheng Y; Cai H; Lu W; Shu XO
    PLoS One; 2013; 8(9):e75926. PubMed ID: 24098745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative comparison of drug efficacy in treating hot flashes in patients with breast cancer.
    Li T; Yang J; Lv Y; Yin F; Xu L; Liu H; Zheng Q; Li L
    Breast Cancer Res Treat; 2019 Feb; 173(3):511-520. PubMed ID: 30390215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
    Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
    Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of breast cancer treatment on the occurrence of hot flashes.
    Savard MH; Savard J; Quesnel C; Ivers H
    J Pain Symptom Manage; 2009 Apr; 37(4):687-97. PubMed ID: 18973980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial.
    Van Patten CL; Olivotto IA; Chambers GK; Gelmon KA; Hislop TG; Templeton E; Wattie A; Prior JC
    J Clin Oncol; 2002 Mar; 20(6):1449-55. PubMed ID: 11896091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial.
    Mao JJ; Bowman MA; Xie SX; Bruner D; DeMichele A; Farrar JT
    J Clin Oncol; 2015 Nov; 33(31):3615-20. PubMed ID: 26304905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: A systematic review and meta-analysis.
    Hervik JB; Stub T
    Breast Cancer Res Treat; 2016 Nov; 160(2):223-236. PubMed ID: 27709351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients.
    He W; Smedby KE; Fang F; Olsson H; Margolin S; Hall P; Czene K
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28423398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.
    Pandya KJ; Raubertas RF; Flynn PJ; Hynes HE; Rosenbluth RJ; Kirshner JJ; Pierce HI; Dragalin V; Morrow GR
    Ann Intern Med; 2000 May; 132(10):788-93. PubMed ID: 10819701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.